ATLASCogent Biosciences (COGT) Q3 2026 earnings results
Cogent Biosciences (COGT) reported EPS of -$0.59 against an analyst estimate of -$0.57: a miss of $0.02 (3.5%). The quarter ended Sep 30, 2026; the company reported on Friday, November 6, 2026.
Status: Confirmed · 06:00 ET, Nov 6 · Source: EODHD (calendar and fundamentals, cross-checked)
Get an email before and after Cogent Biosciences reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountCOGT Q3 2026 results at a glance
| EPS reported | -$0.59 |
|---|---|
| EPS estimate | -$0.57 |
| Surprise | Miss · -$0.02 (-3.5%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Nov 6, 2026 |
| Status | Confirmed · 06:00 ET, Nov 6 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Cogent Biosciences’s Q3 2026, a calendar-year company.
Cogent Biosciences EPS surprise history: last 4 quarters
Cogent Biosciences beat the EPS estimate in 2 of its last 4 reports, with an average surprise of +38.9%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 6, 2026 | -$0.57 | -$0.59 | -3.5% | Miss | – |
| Aug 10, 2026 | -$0.56 | -$0.52 | +7.1% | Beat | -8.7% |
| May 5, 2026 | -$0.54 | -$0.53 | +1.9% | In line | -2.3% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | +0.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
COGT stock reaction to the report
The price reaction will be added after the Nov 9, 2026 close.
This section appears once a post-report closing price exists and updates with every new close.
Next COGT earnings report
Cogent Biosciences has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the COGT earnings calendar.
ATLAS fair value and signal for COGT
| Last price | $31.64 (+7.0%) |
|---|---|
| Chance of a higher close in 1 month | 48% (normal range $28.76–$34.43) |
These are model outputs from the same valuation and calibrated model as the Cogent Biosciences stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Cogent Biosciences Q3 2026 earnings: frequently asked questions
Did Cogent Biosciences beat earnings estimates for Q3 2026?
Cogent Biosciences reported EPS of -$0.59 against an analyst estimate of -$0.57: a miss of $0.02 (3.5%).
When did Cogent Biosciences report Q3 2026 results?
Cogent Biosciences reported on Friday, November 6, 2026, for the quarter ended Wednesday, September 30, 2026.
How often does COGT beat EPS estimates?
In its last 4 reports with a recorded result, Cogent Biosciences beat the EPS estimate 2 times; the average surprise was +38.9%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer